Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Angiology: Open Access|November 7, 2014
Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of AngiosarcomaVittal Kurisetty, Brad A BryanBMC Clinical Pathology|September 29, 2015
Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumorsClarissa N Amaya, Brad A BryanMethods in Enzymology|September 6, 2008
Pericyte isolation and use in endothelial/pericyte coculture modelsBrad A Bryan, Patricia A D'AmoreAnticancer Research|November 24, 2011
Rho kinase proteins--pleiotropic modulators of cell survival and apoptosisCatharine A Street, Brad A BryanJournal of Cellular Biochemistry|July 14, 2010
Anti-angiogenic therapy: adapting strategies to overcome resistant tumorsDianne C Mitchell, Brad A BryanVeterinary Sciences|October 25, 2017
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and HemangiosarcomaErin B Dickerson, Brad A BryanJournal of Neuroscience Research|February 24, 2006
The Rho-family guanine nucleotide exchange factor GEFT enhances retinoic acid- and cAMP-induced neurite outgrowthBrad A Bryan, Yi Cai, Mingyao LiuArchives of Microbiology|September 7, 2004
Nutrient-specific effects in the coordination of cell growth with cell division in continuous cultures of Saccharomyces cerevisiaeJinbai Guo, Brad A Bryan, Michael PolymenisOncoscience|November 22, 2018
Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatmentDana C Galván, Anoop P Ayyappan, Brad A BryanOncoscience|October 15, 2019
Correction: Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatmentDana C Galván, Anoop P Ayyappan, Brad A BryanPageof 5